myeloproliferative-neoplasms

What Are Myeloproliferative Neoplasms?

Myeloproliferative Neoplasms (MPNs)–also known as myeloproliferative disorders–are a class of blood cancers that are rooted within the bone marrow which is where blood cells are created. These conditions cause bone marrow to create more blood cells than it can handle which include the red blood cell (RBCs), white blood cells (WBCs), or platelets.

MPNs can be diagnosed at any time, but they are more prevalent in older people. For some people MPNs, they progress slowly and with no signs, but in others, they could develop into more serious diseases like acute myeloidleukemia (AML).

Understanding Blood and Bone Marrow

The bone marrow produces three major kinds of blood cells.

• RBCs (RBCs): Carry carbon dioxide and oxygen. A low count can cause anemia, which can cause weakness and fatigue.

• WBCs (WBCs): Fight infections. Insufficient WBCs could make it more likely for infection.

• Platelets Aid in blood clotting. Insufficient levels can lead to bleeding or bruising.

Stem cells in the bone marrow grow into blood cells. In MPNs abnormally signaling, it causes excessive production or malfunction in the development of a particular blood cell types.

Types of Myeloproliferative Neoplasms

MPNs are classified by the blood type affected. The most important subtypes are:

1. Primary Myelofibrosis (PMF)

• Influences RBCs and Granulocytes (a kind of WBC)

• Scarring (fibrosis) of bone Marrow

• This causes fatigue, anemia and an enlarged spleen.

2. Polycythemia Vera (PV)

• The production of red blood cells is increased.

• The blood thickens and raises the chance of clotting

• Signs: Headache Itching, dizziness, headache an increase in the size of the spleen.

3. Essential Thrombocythemia (ET)

• Elevated platelet count

• Increases the risk of bleeding or blood clots

• Symptoms such as headache or vision changes and burning sensations in the feet and hands

4. Chronic Eosinophilic Leukemia / Hypereosinophilic Syndrome (HES)

• Excess Eosinophils (a kind of WBC which fights allergies and parasites)

• It can cause tissue damage and swelling. They can also trigger allergic reactions.

• It could be able to progress to AML

5. Systemic Mastocytosis (SM)

• The abnormal growth of mast cells in organs

• The GI tract, skin and spleen. It also affects liver, spleen and bone the marrow

• The symptoms include skin redness, abdominal pain and flushing

Risk Factors for Myeloproliferative Neoplasms

Certain factors could increase the likelihood of developing MPNs.

• advanced age (common for people who are older than 60)

• Genetic changes specifically those in JAK2 gene JAK2 gene

• Radiation exposure (e.g., nuclear incidents)

• Chemical exposure (benzene, toluene, tobacco smoke)

• History of the family (some MPNs may be passed down)

Symptoms of Myeloproliferative Neoplasms

MPNs in early stages may not be symptomatic. If symptoms do develop they can include:

• Insufficiency or fatigue

• Headache or dizziness

• Breathing shortness

• Simple bleeding or bruising

• Petechiae (tiny tiny red patches on your skin)

• Night sweats, fever or fever

• Itching (especially after an intense shower)

• Unintentional weight loss

If you are experiencing some of these signs, you should consult an hematologist immediately.

Treatment Options for Myeloproliferative Neoplasms

Treatment is dependent on MPN type, severity, and signs. The goal is to reduce blood count, limit the risk of complications, and to prevent progress. Treatment options for common ailments include:

Medications

• Hydroxyurea and anagrelide interferon alpha: Used to regulate blood cell counts in PV as well as ET.

• Ruxolitinib and fedratinib: JAK inhibitors for myelofibrosis and PV (if not responsive to the hydroxyurea)

• Aspirin: Helps prevent blood clots

• Thermoporoids, steroids Cladribine: In particular subtypes

Other Therapies

• Phlebotomy Get rid of excess red blood cell from PV

• Transfusions of blood or platelet: For anemia or low platelet count

• The growth factors Enhance bone marrow growth

• Therapy with radiation: Used for spleen-related symptoms of myelofibrosis

• Splenectomy Surgery to remove the spleen for certain conditions

Ongoing Management & Follow-Up

MPNs require ongoing management and frequent monitoring. Your hematologist will develop your treatment plan based upon the type of MPN you have, your responses to treatments, and general health. Early detection and consistent treatment can greatly improve your overall health and outcome.